QuidelOrtho (QDEL) | Stock Overview & Key Data
QuidelOrtho Performance Comparison
Stock Range
Today's Range
Low: $26.78
High: $28.07
on October 8, 2025
52 Week Range
Low: $22.05
High: $49.45
on August 1, 2025
on January 7, 2025
All-Time High: $306.72 on August 3, 2020
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.9B
EPS
-6.84
P/E Ratio (TTM)
-0.92
Forward P/E
10.45
P/B Ratio
0.67
PEG Ratio
-0.01
Div. Yield
N/A
ROE
-15.64%
Beta
0.268
Debt to Equity
100.33
Financial Highlights
Profitability
Gross Margin
44.78%
Operating Margin
-0.73%
Profit Margin
-17.01%
Returns and Earnings
Return on Assets (TTM)
1.36%
Return on Equity (TTM)
-15.64%
EBITDA
$542.4M
Net Income (TTM)
$-466.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$40.76
Quarterly Revenue Growth (YoY)
-3.60%
Quarterly Earnings Growth (YoY)
-3.63%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| QuidelOrtho QDEL | 1.89B Small-cap | -10.85% | -2.14% | -9.60% | 6.34% | -38.14% | -32.13% | -63.48% | -89.09% |
| Abbott Laboratories ABT | 231.52B Mega-cap | 0.60% | 1.57% | 0.68% | 8.33% | 18.36% | 15.63% | 33.06% | 22.43% |
| Boston Scientific BSX | 142.10B Large-cap | 0.98% | -10.50% | -5.49% | 6.79% | 8.29% | 11.13% | 142.10% | 151.80% |
| Bio-Rad BIO.B | 7.92B Mid-cap | 0.00% | 15.31% | 13.92% | 17.72% | -12.51% | -14.92% | -28.29% | -46.25% |
| Bio-Rad Laboratories BIO | 8.14B Mid-cap | 1.64% | 4.29% | 20.78% | 37.33% | -7.15% | -10.12% | -23.28% | -45.59% |
| Globus Medical GMED | 8.28B Mid-cap | 3.00% | 1.46% | 6.75% | -11.98% | -26.16% | -14.38% | -0.58% | 9.14% |
Ownership & Short Interest
Insider Ownership
0.92%
Institutional Ownership
117.24%
Shares Short
8M
Short Ratio
7.03
Short % of Shares Outstanding
19.95%
Average 10-Day Volume
1M
Average 90-Day Volume
1M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is QDEL's 52-week high and low?
- In the last 52 weeks, QuidelOrtho reached a high of $49.45 (on January 7, 2025) and a low of $22.05 (on August 1, 2025).
- What is the market cap and P/E ratio for QDEL?
- Curious about QuidelOrtho's size and valuation? Its market capitalization stands at 1.89B. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.92, and the forward P/E (looking ahead) is 10.45.
- Does QDEL pay dividends? If so, what's the yield?
- As for dividends, QuidelOrtho isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are QuidelOrtho's main competitors or similar companies to consider before investing?
When looking at QuidelOrtho, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT231.52B Healthcare Medical Devices 15.63% 33.06% Boston Scientific
BSX142.10B Healthcare Medical Devices 11.13% 142.10% Bio-Rad
BIO.B7.92B Healthcare Medical Devices -14.92% -28.29% Bio-Rad Laboratories
BIO8.14B Healthcare Medical Devices -10.12% -23.28% Globus Medical
GMED8.28B Healthcare Medical Devices -14.38% -0.58% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for QuidelOrtho Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of QuidelOrtho's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -15.64%, the Debt to Equity ratio from the most recent quarter is 100.33, and its Gross Profit Margin stands at 44.78%.
- What is the recent revenue and earnings growth for QDEL?
- Looking at QuidelOrtho's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by -3.60%, and quarterly earnings saw a YoY growth of -3.63%.
- How much of QDEL stock is held by insiders and institutions?
- Wondering who owns QuidelOrtho stock? Company insiders (like executives and directors) hold about 0.92% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 117.24%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.